SCHEMBL20180580

SCHEMBL20180580

COC(=O)c1ccc2c(-c3ccccc3Cl)c(C)n(-c3ccc(F)cc3)c2c1

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 18/20 0.64
USP14 P54578 1/20 0.47
MAPK8 P45983 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20180361 0.89 DGAT2 (0.52) DGAT2MAPK8
SCHEMBL20180268 0.88 DGAT2 (0.62) DGAT2
SCHEMBL20166203 0.86 DGAT2 (0.66) DGAT2MAPK8
SCHEMBL20166496 0.80 DGAT2 (0.70) DGAT2
SCHEMBL20166183 0.79 DGAT2 (1.00) DGAT2
SCHEMBL20167169 0.78 DGAT2 (0.75) DGAT2
SCHEMBL20180267 0.78 DGAT2 (0.51) DGAT2
SCHEMBL20166273 0.73 DGAT2 (0.63) DGAT2
SCHEMBL347648 0.72 DGAT2 (0.58) DGAT2
SCHEMBL20166313 0.71 DGAT2 (0.65) DGAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541376-B1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME LLC (US) 2023-04-19 EP disclosed
US-10947222-B2 Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 MERCK SHARP & DOHME CORP. (US) 2021-03-16 US disclosed
US-10947222-B2 Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 MERCK SHARP & DOHME CORP. (US) 2021-03-16 US disclosed
US-20190276443-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2019-09-12 US disclosed
US-20190276443-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2019-09-12 US disclosed
WO-2018093698-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947222-B2 Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 DGAT2, DGAT1, MOGAT2 DGAT2 1/4885USP14 3370/4885MAPK8 3689/4885
US-20190276443-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 DGAT2, DGAT1, MOGAT2 DGAT2 1/4885USP14 3370/4885MAPK8 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.